NOVT · NASDAQ · Hardware, Equipment & Parts

Novanta (NOVT)

Precision motion, laser, robotics and surgical technologies for medical and industrial equipment makers.

$136.61
vs last close+2.30 (+1.71%)
Loading prices…

Novanta Inc.NOVT
Information Technology

Supplies precision components, subsystems and surgical consumables to medical, life science and advanced-industrial OEMs through Automation Enabling Technologies and Medical Solutions. Revenue comes mainly from engineered placements in long-life equipment platforms, with meaningful exposure to a small number of medical customers.

Supplies precision components, subsystems and consumables to medical, life science and advanced-industrial equipment makers. Automation Enabling Technologies spans laser beam steering and sources, robotic and precision motion, end-of-arm tooling and air-bearing spindles. Medical Solutions covers insufflators, endoscopic pumps and disposables, imaging and RFID, motion control, light engines and integrated operating-room systems; Riverpoint adds surgical fibers and related minimally invasive consumables.

Wins long-cycle OEM placements by tailoring proprietary hardware and software to demanding applications, then sells mainly through technical direct-sales teams. Operations and customers span North America, Europe and Asia, with manufacturing distributed across those regions.

Revenue depends on OEM design cycles, hospital and industrial capital spending, medical-device regulation and acquisition integration. A small number of medical OEM customers account for a meaningful share of sales.

Company facts

CEOMatthijs Glastra
ListedMar 24, 1999
ExchangeNASDAQ
HeadquartersBedford, MA
CountryUnited States
Employees3,000
CIK0001076930
ISINCA67000B1040

Market cap$4.78B
EPS (ttm)$1.56
P/E (ttm)86.10
ROE4.9%
P/B2.96
P/S4.65
Dividend yieldDiv yield
Beta1.95vs XLK 0.22

Price target$194.00+44.4%Average of 3 analysts
ConsensusBuy2 of 3 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 7, 2026Robert W. BairdTarget
Target: $180
Target: $194
Jun 9, 2026Robert W. BairdTarget
Target: $150
Target: $180
Mar 30, 2026BairdUpgrade
Rating: Neutral
Rating: Outperform
Feb 25, 2026Robert W. BairdTarget
Target: $160
Target: $150

Next report
Nov 2, 26
in 41 days
EPS estimate
$0.97
Revenue estimate
$301.0M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.76$0.74$0.76$0.87$0.91$0.81$0.89Pending
Estimate$0.81$0.68$0.74$0.81$0.88$0.78$0.83$0.97
Surprise−6.2%+8.8%+2.7%+7.4%+3.4%+3.8%+7.2%

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$238.1M$233.4M$241.0M$247.8M$258.3M$257.7M$265.8MPending
Estimate$244.6M$240.7M$248.5M$255.6M$255.6M$253.4M$262.3M$301.0M
Surprise−2.7%−3.1%−3.0%−3.0%+1.1%+1.7%+1.3%
Estimate$0.97
ReportedDue Nov 2, 2026
Estimate$301.0M
ReportedDue Nov 2, 2026
View details

Debt to equity17.50%
Current ratio456.90%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$244.4M$238.1M$233.4M$241.0M$247.8M$258.3M$257.7M$265.8M
Net income$19.2M$16.5M$21.2M$4.5M$10.7M$17.5M$21.1M$12.5M
Net margin7.9%6.9%9.1%1.9%4.3%6.8%8.2%4.7%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$32.6M$26.7M$30.0M$27.5M$28.5M$30.7M$30.1M$18.1M
YoY growth+7.4%+23.2%+17.0%+6.9%−12.4%+14.9%+0.6%−34.3%

Balance sheet, Jul 3, 2026Cash & short-term investments $718.7M · Total debt $282.8M · Total assets $2.14B · Shareholders' equity $1.62B

Revenue
$265.8M
Operating income
$18.1M
Net income
$12.5M
View details

No dividends on record.

Institutions≈ 117.50%44.44M shares
408 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail
Insiders0.57%214.4K shares
13 holders · as of Sep 15, 2026
Strategic holders4.61%1.74M shares
1 holder · as of Feb 4, 2020
Adds to122.68%

37.82M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

These groups come from separate filings that can overlap, so they add to 122.68%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
BlackRock, Inc.Institution
12.69%4.80Mas of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution
6.33%2.40Mas of Jun 30, 2026
Price T Rowe Associates Inc /MD/Institution
5.88%2.22Mas of Jun 30, 2026
Allspring Global Investments Holdings, LLCInstitution
4.81%1.82Mas of Jun 30, 2026
Wells Fargo & CompanyStrategic
4.61%1.74Mfiled Feb 4, 2020

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Sep 11, 2026Thomas N. Secordirector−663$147.60
Jul 2, 2026Matthijs Glastradirector, officer: Chief Executive Officer−6,500$161.13
Jun 2, 2026Matthijs Glastradirector, officer: Chief Executive Officer−6,500$168.66
May 12, 2026Matthijs Glastradirector, officer: Chief Executive Officer−7,500$150.43
May 5, 2026Matthijs Glastradirector, officer: Chief Executive Officer−6,500$131.13
View details

  • MKS

    Broad photonics and motion overlap in industrial OEM subsystems

  • Coherent

    Laser and optics scale competitor across precision applications

  • Stryker

    Surgical visualization and insufflation rival in the OR

  • Zebra Technologies

    RFID, barcode, and machine-vision overlap in asset automation

  • Cognex

    Machine vision and barcode rival in automation workflows

  • Teledyne Technologies

    Imaging, sensors, and instrumentation peer for OEM systems

  • Allient

    Precision motion rival in medical and industrial equipment

  • IPG Photonics

    Fiber-laser specialist competing in laser-source niches

Compare

CompanyPriceChange
Novanta$136.61+1.71%$4.78B86.134.24.6+10.3%
MKS$258.23+0.51%$17.35B41.016.54.0+28.3%
Coherent$312.22−2.89%$62.90B78.233.48.8+33.7%
Stryker$275.97+0.65%$105.11B28.417.24.1+9.4%
Zebra Technologies$351.24+0.11%$16.71B33.016.82.9+20.4%
Cognex$59.51−4.00%$10.32B60.231.99.5+16.9%
Teledyne Technologies$607.58−0.25%$28.23B29.423.84.4+9.8%
Allient$110.62+1.16%$1.86B64.336.13.2+10.2%
IPG Photonics$78.17+0.53%$3.30B119.641.23.1+11.1%
Median50.627.84.0+14.0%